JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torchiana, M. L.
Right arrow Articles by Clineschmidt, B. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torchiana, M. L.
Right arrow Articles by Clineschmidt, B. V.

Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1- piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1- oxide (L-643, 441)

ML Torchiana, RG Pendleton, PG Cook, CA Hanson and BV Clineschmidt

L-643,441 is a highly potent histamine H2-receptor antagonist in guinea- pig atria, acting via a unique mechanism. Unlike ranitidine, the onset of action of this compound was slow and its inhibitory action persisted after repeated washing of the tissues. Preincubation of atria with ranitidine, however, protected the H2-receptor from the apparently irreversible antagonism of L-643,441. H2-receptor antagonism produced by L-643,441 was not surmountable by increasing the concentration of dimaprit. The compound did not alter the response of this tissue to isoproterenol or affect basal atrial rate under conditions in which maximal H2-receptor blockade was achieved. In dogs, L-643,441 was effective both orally and i.v. in inhibiting gastric acid secretion evoked by histamine, gastrin, 2-deoxy-D-glucose and food. Orally, it was equipotent with ranitidine against histamine-induced secretion, but the duration of action of L-643,441 was substantially longer.

Volume 224, Issue 3, pp. 514-519, 03/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.